Are you a biopharmaceutical company eager to launch your first EU-approved drug in France? Don’t let the complex and lengthy process of establishing a compliant subsidiary slow you down.
Discover key insights on:
How a pharmaceutical company cut 18 months off the standard timeline for establishing its authorized local subsidiary in France.
The primary and secondary goals of rapidly setting up a compliant subsidiary and accessing local expertise without unnecessary recruitment.
The challenges of obtaining the “Exploitant” license and navigating the complex regulatory landscape in France.
The step-by-step process required to establish a subsidiary, including recruiting a Responsible Pharmacist, filing the dossier to ANSM, and more.
The successful outcome of entering the French market efficiently while maintaining regulatory compliance.
